Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Long-term Data on Improving OS for Patients With MM
September 13, 2019 – 
Long-term data for depth of response and the length of overall survival (OS) are examined in patients with multiple myeloma (MM).
Payer Perspective: Transplant and Toxicities in MM Therapy
September 13, 2019 – 
John Fox, MD, MHA, provides a cost perspective on transplant as a standard of care and discusses associated toxicities in patients with multiple myeloma (MM).
Tests Involved in a Diagnostic Work-Up of Multiple Sclerosis
September 12, 2019 – 
A comprehensive review of the specific tests utilized in the differential diagnosis of multiple sclerosis.
Multiple Sclerosis: Making a Diagnosis
September 12, 2019 – 
Shifting their focus to diagnosis of multiple sclerosis, experts discuss symptoms, comorbid conditions, and relevant criteria.
Is Multiple Sclerosis Truly an Autoimmune Disease?
September 05, 2019 – 
Key opinion leaders debate the understanding that multiple sclerosis is truly an autoimmune disease.
The Nature and Cost of Multiple Sclerosis
September 05, 2019 – 
A panel of experts digs into the nature of multiple sclerosis, further considering its incidence and cost.
FORTE Trial: Transplant in Patients with Multiple Myeloma
August 30, 2019 – 
The implications of the FORTE trial are explored with regard to PFS with transplant and classification of high-risk and low-risk patients in multiple myeloma.
Impact of Maintenance Therapy in Multiple Myeloma
August 30, 2019 – 
The impact of maintenance therapy in improving overall survival and the importance of real-world data is examined in multiple myeloma management.
Strategy for Up-front Therapy of Multiple Myeloma
August 23, 2019 – 
Expert panelists provide their perspectives on up-front therapy in multiple myeloma, along with emerging drugs in the field.
Backbone Therapy in Newly Diagnosed Multiple Myeloma
August 23, 2019 – 
John Fox, MD, MHA; Sundar Jagannath, MBBS; and Ola Landgren, MD, PhD; discuss their personal approach to backbone therapy in newly diagnosed multiple myeloma.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.